drugset / Trial / NCT01822860

Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function

NCT01822860

Phase 4 Withdrawn Creighton University
RandomizedCrossoverQuadruple-blindTreatment

Summary

Chlorthalidone will result in improved endothelial function compared to hydrochlorothiazide as measured by flow mediated vasodilatation.

Timeline

Start
2013-03
Primary completion
2015-02
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorthalidone Other / unclassified 12.5 mg
Comparator Hydrochlorothiazide Unknown 25 mg

Indications